Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
CPT: Pharmacometrics & Systems Pharmacology
|
February 26, 2026
Population PK/PD Modeling for Evaluation of Intertwining Effects of Drug and Disease on Thrombocytopenia in Acute Leukemias
Tomás Sou, Kamel Malek, Hans-Jochen Weber
Statistics in Medicine
|
September 16, 2025
Towards Efficient Time-to-Event Dose-Escalation Guidance of Multi-Cycle Cancer Therapies
Lukas A Widmer, Sebastian Weber, Yunnan Xu, et al.
Pharmaceutical Statistics
|
March 9, 2021
Estimands in hematologic oncology trials
Steven Sun, Hans-Jochen Weber, Emily Butler, et al.
Pharmaceutical Statistics
|
March 29, 2024
Time-to-event estimands and loss to follow-up in oncology in light of the estimands guidance
Jonathan M Siegel, Hans-Jochen Weber, Stefan Englert, et al.
Pharmaceutical Statistics
|
March 27, 2023
Quantification of follow-up time in oncology clinical trials with a time-to-event endpoint: Asking the right questions
Kaspar Rufibach, Lynda Grinsted, Jiang Li, et al.
Pulmonary Pharmacology & Therapeutics
|
January 15, 2009
Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma
Søren Pedersen, Renate Engelstätter, Hans-Jochen Weber, et al.
Pharmaceutical Statistics
|
October 3, 2023
Duration of and time to response in oncology clinical trials from the perspective of the estimand framework
Hans-Jochen Weber, Stephen Corson, Jiang Li, et al.
Expert Opinion on Pharmacotherapy
|
October 21, 2010
Efficacy and safety of ciclesonide in patients with severe asthma: a 12-week, double-blind, randomized, parallel-group study with long-term (1-year) follow-up
Brian J O'Connor, Stephen Kilfeather, David Cheung, et al.
Haematologica
|
October 21, 2017
Panobinostat monotherapy and combination therapy in patients with acute myeloid leukemia: results from two clinical trials
Richard F Schlenk, Jürgen Krauter, Emmanuel Raffoux, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
CPT: Pharmacometrics & Systems Pharmacology
|
February 26, 2026
Population PK/PD Modeling for Evaluation of Intertwining Effects of Drug and Disease on Thrombocytopenia in Acute Leukemias
Tomás Sou, Kamel Malek, Hans-Jochen Weber
Statistics in Medicine
|
September 16, 2025
Towards Efficient Time-to-Event Dose-Escalation Guidance of Multi-Cycle Cancer Therapies
Lukas A Widmer, Sebastian Weber, Yunnan Xu, et al.
Pharmaceutical Statistics
|
March 9, 2021
Estimands in hematologic oncology trials
Steven Sun, Hans-Jochen Weber, Emily Butler, et al.
Pharmaceutical Statistics
|
March 29, 2024
Time-to-event estimands and loss to follow-up in oncology in light of the estimands guidance
Jonathan M Siegel, Hans-Jochen Weber, Stefan Englert, et al.
Pharmaceutical Statistics
|
March 27, 2023
Quantification of follow-up time in oncology clinical trials with a time-to-event endpoint: Asking the right questions
Kaspar Rufibach, Lynda Grinsted, Jiang Li, et al.
Pulmonary Pharmacology & Therapeutics
|
January 15, 2009
Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma
Søren Pedersen, Renate Engelstätter, Hans-Jochen Weber, et al.
Pharmaceutical Statistics
|
October 3, 2023
Duration of and time to response in oncology clinical trials from the perspective of the estimand framework
Hans-Jochen Weber, Stephen Corson, Jiang Li, et al.
Expert Opinion on Pharmacotherapy
|
October 21, 2010
Efficacy and safety of ciclesonide in patients with severe asthma: a 12-week, double-blind, randomized, parallel-group study with long-term (1-year) follow-up
Brian J O'Connor, Stephen Kilfeather, David Cheung, et al.
Haematologica
|
October 21, 2017
Panobinostat monotherapy and combination therapy in patients with acute myeloid leukemia: results from two clinical trials
Richard F Schlenk, Jürgen Krauter, Emmanuel Raffoux, et al.
Page
of 1